Overview

Study to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung Transplantation

Status:
Completed
Trial end date:
2019-05-07
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and efficacy of intravenous GLASSIA® treatment in lung transplantation.
Phase:
Phase 2
Details
Lead Sponsor:
Kamada, Ltd.
Treatments:
Alpha 1-Antitrypsin